U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 16:25:19 GMT 2025
Edited
by admin
on Tue Apr 01 16:25:19 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
C78148TF1D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
POGALIZUMAB
WHO-DD  
INN  
Preferred Name English
VONLEROLIZUMAB
INN   USAN  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4(TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4 (ACT35 ANTIGEN, OX40L RECEPTOR, CD134 ANTIGEN))HUMANIZED MOUSE MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED MOUSE VH (HOMO SAPIENS IGHV1-46*01 (81%)
Systematic Name English
R0-7021608
Code English
Vonlerolizumab [WHO-DD]
Common Name English
RG7888
Code English
vonlerolizumab [INN]
Common Name English
MOXR-0916
Code English
R07021608
Code English
RG-7888
Code English
MOXR0916
Code English
VONLEROLIZUMAB [USAN]
Common Name English
Code System Code Type Description
CAS
1638935-72-4
Created by admin on Tue Apr 01 16:25:19 GMT 2025 , Edited by admin on Tue Apr 01 16:25:19 GMT 2025
PRIMARY
NCI_THESAURUS
C121376
Created by admin on Tue Apr 01 16:25:19 GMT 2025 , Edited by admin on Tue Apr 01 16:25:19 GMT 2025
PRIMARY
INN
10272
Created by admin on Tue Apr 01 16:25:19 GMT 2025 , Edited by admin on Tue Apr 01 16:25:19 GMT 2025
PRIMARY
SMS_ID
100000179981
Created by admin on Tue Apr 01 16:25:19 GMT 2025 , Edited by admin on Tue Apr 01 16:25:19 GMT 2025
PRIMARY
FDA UNII
C78148TF1D
Created by admin on Tue Apr 01 16:25:19 GMT 2025 , Edited by admin on Tue Apr 01 16:25:19 GMT 2025
PRIMARY
USAN
DE-168
Created by admin on Tue Apr 01 16:25:19 GMT 2025 , Edited by admin on Tue Apr 01 16:25:19 GMT 2025
PRIMARY
From To
1_22 1_96
1_144 1_200
1_261 1_321
1_367 1_425
2_22 2_96
2_144 2_200
2_261 2_321
2_367 2_425
1_220 3_214
2_220 4_214
1_226 2_226
1_229 2_229
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_297
N 2_297
Related Record Type Details
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4
TARGET -> AGONIST
Related Record Type Details
VONLEROLIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966